Document Detail

A decade of clinical trial developments in postmyocardial infarction, congestive heart failure, and sustained ventricular tachyarrhythmia patients: from CAST to AVID and beyond. Cardiac Arrhythmic Suppression Trial. Antiarrhythmic Versus Implantable Defibrillators.
MedLine Citation:
PMID:  9727666     Owner:  NLM     Status:  MEDLINE    
Multiple trials using antiarrhythmic drugs, pharmacologic therapy, and implantable cardioverter defibrillators have been performed in an attempt to improve survival in patients: (1) postmyocardial infarction; (2) with congestive heart failure, with and without nonsustained ventricular tachycardia; and (3) with sustained ventricular tachycardia and those who have survived an out-of-hospital cardiac arrest. This article reviews some of the key findings and limitations of completed and ongoing trials. We also make recommendations for the current treatment of such patients based on the results of these trials.
G V Naccarelli; D L Wolbrette; J T Dell'Orfano; H M Patel; J C Luck
Related Documents :
380436 - Bretylium tosylate: a newly available antiarrhythmic drug for ventricular arrhythmias.
25351576 - Microrna induced cardiac reprogramming in vivo: evidence for mature cardiac myocytes an...
22476606 - 2011 riley heart center symposium on cardiac development: development of the cardiac co...
14638546 - Implantable cardioverter-defibrillator therapy for prevention of sudden death in patien...
9506706 - Experimental autoimmune myocarditis produced by adoptive transfer of splenocytes after ...
18773986 - Costs and clinical outcomes in individuals without known coronary artery disease underg...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Journal of cardiovascular electrophysiology     Volume:  9     ISSN:  1045-3873     ISO Abbreviation:  J. Cardiovasc. Electrophysiol.     Publication Date:  1998 Aug 
Date Detail:
Created Date:  1998-11-20     Completed Date:  1998-11-20     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9010756     Medline TA:  J Cardiovasc Electrophysiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  864-91     Citation Subset:  IM    
Section of Cardiology and Cardiovascular Center, Penn State University College of Medicine, Hershey, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic beta-Antagonists / therapeutic use
Anti-Arrhythmia Agents / therapeutic use
Clinical Trials as Topic
Defibrillators, Implantable
Heart Failure / therapy*
Myocardial Infarction / therapy*
Tachycardia, Ventricular / therapy*
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Anti-Arrhythmia Agents
Comment In:
J Cardiovasc Electrophysiol. 1999 Mar;10(3):420-1   [PMID:  10210508 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Electrical proarrhythmia: induction of inappropriate atrial therapies due to far-field R wave overse...
Next Document:  Mechanisms of atrial fibrillation: mother rotors or multiple daughter wavelets, or both?